Stocks
2975165BJS
YHDHealthcarePharmaceuticals
A specialty pharmaceutical company focused on developing and commercializing treatments for central nervous system disorders, with a pipeline targeting conditions such as depression and schizophrenia. The company has a market presence in the psychiatric medication space and is tracked by investors for its product development milestones and regulatory approvals.
Congressional Interest in 2975165 (BJS)
1 member of Congress has disclosed 1 trade in 2975165 (BJS), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading BJS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-05-04 | MICHAEL T. MCCAUL | sell | $15K-$50K |